#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arterial tortuosity syndrome Huntington's disease Factor VIII deficiency IPEX syndrome Marginal zone lymphoma recurrent Haemolytic uraemic syndrome Acute promyelocytic leukaemia Cutaneous T-cell lymphoma stage I Oesophageal atresia Cushing's syndrome Autoimmune myositis Infertility male Immune-mediated enterocolitis Acquired haemophilia Rett syndrome More trials…

    Learn about Rare Diseases

    Advanced systemic mastocytosis – Basic Information Ewing’s sarcoma recurrent – Basic Information Erdheim-Chester disease – Trials in Disease Pemphigoid – Trials in Disease Epidermolysis bullosa – Treatment Encephalitis autoimmune – Trials in Disease Advanced systemic mastocytosis – Diagnostics Angiosarcoma metastatic – Basic Information Marfan’s syndrome Lymphangioma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    TAGRAXOFUSP BRENSOCATIB SALICYLIC ACID Phenol, Liquefied Rifapentine GSKVX000000025896 Sodium Valproate Rezvilutamide Betula Pollen Extract Erythromycin Vibozilimod Bi 764532 Azithromycin Ep0042 Baricitinib Lutetium (177Lu) Oxodotreotide 177Lu-Dpi-4452 Dexchlorpheniramine Molgramostim Teprotumumab More therapies…

    Learn about Your Condition

    Atrial fibrillation Hypertrophic scar Traumatic pain Scoliosis Becker's muscular dystrophy Proteus syndrome Tonsillitis Pulmonary tuberculosis Hypertrophic cardiomyopathy Acarodermatitis Venous thrombosis limb Papillary thyroid cancer Eructation Hypertriglyceridaemia Asthmatic crisis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study Evaluating Direct Oral Anticoagulants for Prevention of Blood Clots in Patients with Hypertrophic Cardiomyopathy and Abnormal Left Atrial Function

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypertrophic cardiomyopathy
    Investigated Drugs:
    • Rivaroxaban
    France

  • Study of THEO-260 for Patients with High-Grade Serous or Endometrioid Ovarian Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Ovarian cancer
    Spain

  • Evaluating Morphine Effectiveness Based on Kidney Function in Patients with Sickle Cell Disease During Vaso-occlusive Crisis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sickle cell anaemia
    Investigated Drugs:
    • Morphine Hydrochloride
    • Iohexol
    France

  • Study of Regorafenib and Maintenance Chemotherapy for Newly Diagnosed Ewing Sarcoma Patients with Metastatic Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma
    Investigated Drugs:
    • Vinorelbine
    • Cyclophosphamide
    Denmark France The Netherlands Norway Spain

  • Evaluating Dapagliflozin’s Effect on Immune Activity in Patients with Membranous Nephropathy

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Glomerulonephritis membranous
    Investigated Drugs:
    • Dapagliflozin
    France

  • Study of Trastuzumab Deruxtecan, Rilvegostomig, and Pembrolizumab for Advanced or Recurrent Endometrial Cancer in HER2-Positive Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Infliximab
    • Docetaxel
    • Mycophenolate Mofetil
    Austria Belgium Denmark Finland France Germany +7
Previous Page
1 … 174 175 176 177 178 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!